Skip to main content
SpringerLink
Log in

Approches d’identification des médicaments potentiellement inappropriés chez la personne âgée

Approaches to Identify Potentially Inappropriate Medications in Elderly

  • Article de Synthèse / Review Article
  • Published:
Les cahiers de l'année gérontologique

Résumé

Les risques liés à la prescription médicamenteuse, et en particulier ceux liés à la iatrogénie, sont majorés chez la personne âgée. L’identification des médicaments potentiellement inappropriés fait aujourd’hui partie intégrante de la stratégie d’optimisation thérapeutique. Cet article a pour objectif d’exposer les trois principales approches utilisées: les outils explicites, implicites et ceux évaluant la charge médicamenteuse.

Abstract

Risks related to drug prescription, and in particular those related to iatrogenic, are increased in the elderly. Identify potentially inappropriate medications is today an integral part of the therapeutic optimization strategy. This article studies the three main approaches: explicit, implicit tools and those evaluating the drug burden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Haute Autorité de Santé. Prescription Médicamenteuse chez le Sujet Âgé (PMSA) — programme pilote 2006–2013. Disponible sur: http://has-sante.fr/portail/jcms/c_675707/ensemble-amelioronsla-prescription-medicamenteuse-chez-le-sujet-age-pmsa. Consulté le: 30 avril 2014

  2. Insee. Population par âge. Disponible sur: http://www.insee.fr/fr/ffc/tef/tef2013/T13F032/T13F032.pdf. Consulté le: 30 avril 2014

  3. Ferchichi S, Antoine V (2004) Le bon usage des médicaments chez la personne âgée. Rev Med Int 25:582–590

    Article  CAS  Google Scholar 

  4. Spinewine A, Schmader KE, Barber N, et al (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370:173–184

    Article  PubMed  Google Scholar 

  5. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279:1200–1205

    Article  CAS  PubMed  Google Scholar 

  6. Hanlon JT, Lindblad CI, Gray SL (2004) Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am J Geriatr Pharmacother 2:3–13

    Article  PubMed  Google Scholar 

  7. Dimitrow MS, Airaksinen MS, Kivelä SL, A, et al (2011) Comparison of Prescribing Criteria to Evaluate the Appropriateness of Drug Treatment in Individuals Aged 65 and Older: A Systematic Review. J Am Geriatr Soc 59:1521–1530

    Article  PubMed  Google Scholar 

  8. Beers MH, Ouslander JG, Rollingher I, et al (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151:1825–1832

    Article  CAS  PubMed  Google Scholar 

  9. Stuck AE, Beers MH, Steiner A, et al (1994) Inappropriate medication use in community-residing older persons. Arch Intern Med 154:2195–2200

    Article  CAS  PubMed  Google Scholar 

  10. Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157:1531–1536

    Article  CAS  Google Scholar 

  11. Zhan C, Sangl J, Bierman AS, et al (2001) Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 286:2823–2829

    Article  CAS  PubMed  Google Scholar 

  12. Fick DM, Cooper JW, Wade WE, et al (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163:2716–2724

    Article  PubMed  Google Scholar 

  13. American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60:616–631

    Article  Google Scholar 

  14. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 156: 385–391

    CAS  Google Scholar 

  15. Naugler CT, Brymer C, Stolee P, Arcese ZA (2000) Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 7:103–107

    CAS  PubMed  Google Scholar 

  16. Lechevallier-Michel N, Gautier-Bertrand M, Alpérovitch A, et al (2005) Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Eur J Clin Pharmacol 60:813–819

    Article  PubMed  Google Scholar 

  17. Alpérovitch A, Amouyel P, Dartigues JF, et al (2002) Epidemiological studies on aging in France: from the PAQUID study to the Three-City study. C R Biol 325:665–672

    Article  PubMed  Google Scholar 

  18. Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63:725–731

    Article  PubMed  Google Scholar 

  19. Barry PJ, Gallagher P, Ryan C, O’Mahony D (2007) START (screening tool to alert doctors to the right treatment). An evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 36:632–638

    Article  CAS  PubMed  Google Scholar 

  20. Gallagher P, O’Mahony D (2008) STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 37:673–679

    Article  PubMed  Google Scholar 

  21. Lang PO, Hasso Y, Belmin J, et al (2009) STOPP-START: Adaptation en langue française d’un outil de détection de la prescription médicamenteuse inappropriée chez la personne âgée. Can J Public Health 100:426–431

    PubMed  Google Scholar 

  22. Wenger NS, Shekelle PG (2001) Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med 135:642–646

    Article  CAS  PubMed  Google Scholar 

  23. Wenger NS, Roth CP, Shekelle P, the ACOVE Investigators (2007) Introduction to the Assessing Care of Vulnerable Elders-3 Quality Indicator Measurement Set. J Am Geriatr Soc 55:S247–S252

    Article  PubMed  Google Scholar 

  24. Page RL, Linnebur SA, Bryant LL, Ruscin JM (2010) Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 5:75–87

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Fouquet A, Zegbeh H, Krolak-Salmon P, Mouchoux C (2012) Detection of potentially inappropriate medication in a French geriatric teaching hospital: A comparison study of the French Beers criteria and the improved prescribing in the elderly tool. Eur Geriatr Med 3:326–329

    Article  Google Scholar 

  26. Barry PJ, O’Keefe N, O’Connor KA, O’Mahony D (2006) Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 31:617–626

    Article  CAS  PubMed  Google Scholar 

  27. Gallagher PF, O’Connor MN, O’Mahony D (2011) Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 89:845–854

    Article  CAS  PubMed  Google Scholar 

  28. Hanlon JT, Schmader KE, Samsa GP, et al (1992)A method for assessing drug therapy appropriateness. J Clin Epidemiol 45:1045–1051

    Article  CAS  PubMed  Google Scholar 

  29. Lewis T (2004) Using the NO TEARS tool for medication review. BMJ 329:434

    Article  PubMed Central  PubMed  Google Scholar 

  30. Jeffrey S, Ruby C, Twersky J, Hanlon J (1999) Effect of an interdisciplinary team on suboptimal prescribing in a long term care facility. Consult Pharm 14:1386–1391

    Google Scholar 

  31. Steinman MA, Rosenthal GE, Landefeld CS, et al (2007) Conflicts and concordance between measures of medication prescribing quality. Med Care 45:95–99

    Article  PubMed  Google Scholar 

  32. Campbell N, Boustani M, Limbil T, et al (2009) The cognitive impact of anticholinergics: A clinical review. Clin Interv Aging 4:225–233

    PubMed Central  PubMed  Google Scholar 

  33. Lechevallier-Michel N, Molimard M, Dartigues JF, et al (2005) Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol 59:143–151

    Article  PubMed Central  PubMed  Google Scholar 

  34. Carrière I, Fourrier-Reglat A, Dartigues J, et al (2009) Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: The 3-city study. Arch Intern Med 169:1317–1324

    Article  PubMed Central  PubMed  Google Scholar 

  35. Gray SL, LaCroix AZ, Hanlon JT, et al (2006) Benzodiazepine Use and Physical Disability in Community-Dwelling Older Adults. J Am Geriatr Soc 54:224–230

    Article  PubMed Central  PubMed  Google Scholar 

  36. Paterniti S, Dufouil C, Alpérovitch A (2002) Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 22:285–293

    Article  CAS  PubMed  Google Scholar 

  37. Woolcott JC, Richardson KJ, Wiens MO, et al (2009) Metaanalysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169:1952–1960

    Article  PubMed  Google Scholar 

  38. Carnahan RM, Lund BC, Perry PJ, et al (2006) The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 46:1481–1486

    Article  CAS  PubMed  Google Scholar 

  39. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168:508–513

    Article  PubMed  Google Scholar 

  40. Boustani M, Campbell N, Munger S, et al (2008) Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 4:311–320

    Article  CAS  Google Scholar 

  41. Fox C, Richardson K, Maidment ID, et al (2011) Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc 59:1477–1483

    Article  PubMed  Google Scholar 

  42. Han L, Agostini JV, Allore HG (2008) Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc 56:2203–2210

    Article  PubMed Central  PubMed  Google Scholar 

  43. Linjakumpu T, Hartikainen S, Klaukka T, et al (2003) Amodel to classify the sedative load of drugs. Int J Geriatr Psychiatry 18:542–544

    Article  CAS  PubMed  Google Scholar 

  44. Sloane P, Ivey J, Roth M, et al (2008) Accounting for the Sedative and Analgesic Effects of Medication Changes During Patient Participation in Clinical Research Studies: Measurement Development and Application to a Sample of Institutionalized Geriatric Patients. Contemp Clin Trials 29:140–148

    Article  PubMed Central  PubMed  Google Scholar 

  45. Wright RM, Roumani YF, Boudreau R, et al (2009) ffect of Central Nervous System Medication Use on Decline in Cognition in Community-Dwelling Older Adults: Findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 57:243–250

    Article  PubMed Central  PubMed  Google Scholar 

  46. Hanlon JT, Boudreau RM, Roumani YF, et al (2009) Number and Dosage of Central Nervous System Medications on Recurrent Falls in Community Elders: The Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 64:492–498

    Article  PubMed  Google Scholar 

  47. Gnjidic D, Le Couteur DG, Hilmer SN, et al (2014) Sedative load and functional outcomes in community-dwelling older Australian men: the CHAMP study. Fundam Clin Pharmacol 28:10–19

    Article  CAS  PubMed  Google Scholar 

  48. Wright RM, Roumani YF, Boudreau R, et al (2009) Effect of Central Nervous System Medication Use on Decline in Cognition in Community-Dwelling Older Adults: Findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 57:243–250

    Article  PubMed Central  PubMed  Google Scholar 

  49. Boudreau RM, Hanlon JT, Roumani YF, et al (2009) Central nervous system medication use and incident mobility limitation in community elders: the health, aging, and body composition study. Pharmacoepidemiol Drug Saf 18:916–922

    Article  PubMed Central  PubMed  Google Scholar 

  50. Taipale HT, Hartikainen S, Bell JS (2010) A comparison of four methods to quantify the cumulative effect of taking multiple drugs with sedative properties. Am J Geriatr Pharmacother 8:460–471

    Article  CAS  PubMed  Google Scholar 

  51. Hilmer SN, Mager DE, Simonsick EM, et al (2007) A drug burden index to define the functional burden of medications in older people. Arch Intern Med 167:781–787

    Article  PubMed  Google Scholar 

  52. Faure R, Dauphinot V, Krolak-Salmon P, Mouchoux C (2013) A Standard International Version of the Drug Burden Index for Cross-National Comparison of the Functional Burden of Medications in Older People. J Am Geriatr Soc 61:1227–1228

    Article  PubMed  Google Scholar 

  53. Spinewine A, Swine C, Dhillon S, et al (2007) Effect of a Collaborative Approach on the Quality of Prescribing for Geriatric Inpatients: A Randomized, Controlled Trial. J Am Geriatr Soc 55:658–665

    Article  PubMed  Google Scholar 

  54. Kashyap M, Belleville S, Mulsant BH, et al (2014) Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc 62:336–341

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacie, hôpital des Charpennes, hospices civils de Lyon, Lyon, France

    H. Ottomani, C. Loue, M. Viprey & C. Mouchoux

  2. Université Claude Bernard Lyon 1, Lyon, France

    C. Mouchoux

  3. INSERM, U1028, CNRS, UMR5292, centre de recherche des neurosciences, F-69000, Lyon, France

    C. Mouchoux

  4. Centre de recherche clinique « vieillissement, cerveau, fragilité », hôpital des Charpennes, hospices civils de Lyon, 27, rue Gabriel Péri, F-69100, Villeurbanne, France

    C. Mouchoux

Authors
  1. H. Ottomani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Loue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Viprey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Mouchoux
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Pour le groupe « Gériatrie » de la Société française de pharmacie clinique

Corresponding author

Correspondence to C. Mouchoux.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ottomani, H., Loue, C., Viprey, M. et al. Approches d’identification des médicaments potentiellement inappropriés chez la personne âgée. cah. année gerontol. 6, 44–52 (2014). https://doi.org/10.1007/s12612-014-0385-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12612-014-0385-7

Mots clés

Keywords

Search

Navigation